NCT02447393View on ClinicalTrials.gov

Phase 1 Study of Levocetirizine

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 18, 2008

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Dermatitis

Interventions

DRUG

levocetirizine

levocetirizine

DRUG

cetirizine

cetiridine

DRUG

placebo

placebo

Trial Locations (1)

890-0081

GSK Investigational Site, Kagoshima

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY